Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Translation01:31

Translation

18.4K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
18.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Construct validity of instrumented gait assessments in hospital and daily life mobility in patients with Parkinson's disease and atypical Parkinson's syndromes: an exploratory study.

Journal of neurology·2026
Same author

Signs of early cellular dysfunction in multiple system atrophy.

Neuropathology and applied neurobiology·2020
Same author

Development of neurodegeneration in amyotrophic lateral sclerosis: from up or down?

Journal of neural transmission (Vienna, Austria : 1996)·2020
Same author

Sniffing the diagnosis: Olfactory testing in neurodegenerative parkinsonism.

Parkinsonism & related disorders·2016
Same author

Review: Multiple system atrophy: emerging targets for interventional therapies.

Neuropathology and applied neurobiology·2016
Same author

Interventional trials in atypical parkinsonism.

Parkinsonism & related disorders·2015

Related Experiment Video

Updated: Feb 23, 2026

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
15:48

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

10.1K

Key themes and future prospects in translational multiple system atrophy research.

S Eschlboeck1, F Krismer1, G K Wenning1

  • 1Department of Neurology, Medical University of Innsbruck, Anichstraße 35, 6020 Innsbruck, Austria.

Autonomic Neuroscience : Basic & Clinical
|September 5, 2017
PubMed
Summary

Multiple system atrophy (MSA) is a progressive neurodegenerative disease with limited treatment options. Further research and global collaboration are crucial to understand and combat this fatal condition.

Keywords:
Clinical trialsMultiple system atrophySynucleinopathiesTherapies

More Related Videos

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis
08:59

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis

Published on: July 16, 2021

3.2K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

12.1K

Related Experiment Videos

Last Updated: Feb 23, 2026

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
15:48

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

10.1K
Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis
08:59

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis

Published on: July 16, 2021

3.2K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

12.1K

Area of Science:

  • Neurodegenerative diseases
  • Neurology
  • Clinical research

Background:

  • Multiple system atrophy (MSA) is a rare, rapidly progressing neurodegenerative disorder.
  • MSA presents with highly variable clinical symptoms, complicating diagnosis and treatment.
  • Current therapeutic strategies for MSA are limited, with no treatments available to alter disease progression.

Purpose of the Study:

  • To highlight the urgent need for enhanced research into Multiple system atrophy (MSA).
  • To emphasize the necessity of a coordinated global network to address knowledge gaps in MSA.
  • To underscore the importance of advancing our understanding of MSA for future therapeutic development.

Main Methods:

  • Review of current understanding and research challenges in MSA.
  • Identification of critical knowledge gaps in the pathology and clinical progression of MSA.
  • Proposal for a global research network to foster collaborative investigation.

Main Results:

  • Significant research progress has been made in understanding MSA.
  • Substantial knowledge gaps persist regarding MSA's underlying mechanisms and effective treatments.
  • A global, multidisciplinary research network is identified as essential for future progress.

Conclusions:

  • Effective therapies for Multiple system atrophy (MSA) are currently lacking.
  • Addressing the complexities of MSA requires a concerted global research effort.
  • Further investigation and collaboration are imperative to combat this fatal neurodegenerative disease.